Company: HCTI
Filing Date: 2025-02-27
Form Type: 8-K
Source: 0001213900-25-017578
Chunk: 1

Company: Healthcare Triangle, Inc.
Filing Date: 2025-02-27
Form: 8-K
Item: Item 3.01
Chunk 1
---
2024, the Company received a delist
determination letter from the Staff advising the Company that the Staff had determined that the Company did not meet the terms of the
extension, and unless the Company requested an appeal of the Staff’s determination, trading of the Company’s common stock
will be suspended at the opening of business on September 12, 2024. Pursuant to this, the Company requested a hearing on this matter,
which was held on October 24, 2024. A hearing on this matter was held on October 24, 2024, and on November 4, 2024, and December 23, 2024,
the Company received letters from the Nasdaq Hearings Panel (the “Panel”) stating that the Panel has determined to
grant the request of the Company to continue its listing on the Nasdaq Stock Market subject to certain conditions enumerated therein.

Additionally, as previously disclosed, on January
14, 2025, we received a letter from Nasdaq indicating that we were not in compliance with Nasdaq Listing Rules since we have not
yet held an annual meeting of shareholders within twelve months of the Company’s fiscal year end and since the Nasdaq Hearings panel
is currently considering the Company’s continued listing based on another compliance matter(s), the Panel will include the Company’s
annual meeting non-compliance as an additional basis for delisting. The Company has currently scheduled for its 2024 Annual Meeting of
Stockholders to be held on March 28, 2025, and will provide stockholders of record with proxy materials in advance of the Meeting.

2024 Annual Meeting

On February 25, 2025, the Board of Directors (the
“ Board”) of the Company determined that the Company’s 2024 Annual Meeting of Stockholders (the “2024
Annual Meeting”) will be held on March 28, 2025, subject to extension for any comments the Company may receive on the Annual
Meeting Proxy. The time and location of the 2024 Annual Meeting will be set forth in the Company’s definitive proxy statement for
the Annual Meeting to be filed with the Commission (the “ Annual Meeting Proxy”).